FDA Inspection 1178125 — Glenmark Pharmaceuticals Ltd.
The FDA completed an inspection of Glenmark Pharmaceuticals Ltd. on Aug 4, 2022 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE